The combination of large-scale gene screening subject and public welfare program accelerates precision medicine of breast cancer in China
2015.10.26


On Oct. 24, 2015, “Breast Cancer High-Risk Group Gene Screening Subject Phased Progress Experts Exchange Forum, The Launching Ceremony of ‘Keeping You Away from Breast Cancer’ Public Welfare Program”, launched by China Health Promotion Foundation, was held in Shanghai. Professor Chang Yingming (vice president and secretary general of China Health Promotion Foundation, former director of The Second Artillery Force of the PLA Health Department), professor Li Jingbo (vice director of China Health Promotion Foundation Health Management Institute), Ma Jinxiang (director of China Health Promotion Foundation Health Management Department), professor Jiang Jun (the head of Chinese Medical Association Oncology Branch Breast Cancer Group, and director of Third Military Medical University Southwest Hospital Breast Disease Center), Dr. Chen Chongjian (president and CTO of Annoroad) and many clinical experts from more than 40 application research centers attended the forum to discuss the phased research results and the following work of the breast cancer high-risk group screening subject, and held the Launching Ceremony of ‘Keeping You Away from Breast Cancer’ Public Welfare Program.


Organized by China Health Promotion Foundation, and headed by Third Military Medical University Southwest Hospital, Annoroad Gene Technology, as the technology provider, took the lead in carrying out the subject of “breast cancer high-risk group gene screening”, and held the expert forum together with more than 40 application research centers. So far, the subject has achieved some preliminary research results. To promote the breast cancer gene screening from the clinic to the public, and benefit more people, “Breast Cancer High-Risk Group Gene Screening Subject Phased Progress Experts Exchange Forum, The Launching Ceremony of ‘Keeping You Away from Breast Cancer’ Public Welfare Program” also freely released the public welfare program to provide the breast cancer BRCA1/2 gene testing to familial breast cancer patients. 


The Forum was presided over by professor Li Jingbo (vice director of China Health Promotion Foundation Health Management Institute), addressed by professor Chang Yingming (vice president and secretary general of China Health Promotion Foundation), and made a report on the phased summary and expansion plan by professor Jiang Jun (director of Third Military Medical University Southwest Hospital Breast Disease Center). Dr. Chen Chongjian introduced the subject’s contents: high-throughput sequencing platform, biological information analysis, genetic decoding process and quality control, etc. The experts had a heated discussion on research goal, research method, difference of domestic and overseas data, and significance of subject, and the media also asked some questions. 


1446633584640661.jpg

Professor Li Jingbo (vice director of China Health Promotion Foundation Health Management Institute)

 presided over the Forum. 


Professor Chang Yingming (vice president and secretary general of China Health Promotion Foundation) made a speech, and expressed his desire to build the breast cancer high-risk group gene screening model. 

1446633925424242.jpg


In order to carry out the subject research, China Health Promotion Foundation made a decision through discussion to authorize some application center and organizations related to “breast cancer high-risk group gene screening subject”.

1446633683144314.jpg

Professor Jiang Jun, as the head of the subject group, made a phased summary and explained the following work


Professor Jiang Jun reviewed the subject’s progress, and stressed on the target of “building China breast cancer high-risk group and Gene Mutation Database and National Testing Standard”. To this end, professorJiang Jun elaborated upon the statistical result of mutation site of positive samples, propositus’s potentially harmful mutations and the cases show of family tree. In the end, professor Jiang gave a detailed description on the next research planning, especially on the application scheme to form precision clinical diagnosis, precision surgical treatment, precision comprehensive treatment, and precision tracking and monitoring of the breast cancer, based on the breast cancer gene testing big data results, thus realizing the goal of the precision medicine of the breast cancer. 


Dr. Chen Chongjian introduced the subject’s contents: high-throughput sequencing technology platform, biological information analysis, genetic decoding process and quality control.Moreover, Dr. Chen Chongjian also explained the subject’s technical route, biological information analysis and genetic decoding process, and detailed the quality control system of the technology platform to the members of the subject group, and also demonstrated the advantages of Annoroad technology platform in technical stability, degree of process automation and comprehensiveness of report results to the experts. 

1446633707638195.jpg


The experts and reporters conducted a heated discussion on ethical review, domestic and overseas data sharing, pathogenic mutation testing, clinical application specifications, public breast cancer prevention and treatment, etc. with the guest speakers. 

1446633855184631.jpg

The Launching Ceremony of Public Welfare Program


In the end, vice president Chang Yingming, professor Li Jingbo, professor Jiang Jun and Dr. Chen Chongjian jointly launched the “Keeping You Away from Breast Cancer” Public Welfare Program. 

1446633882119508.jpg


分享:

Copyright © Annoroad Gene Technology 京ICP备12029022号-1